Alex Sapir
CEO and President
Replay available
Fulcrum Therapeutics, Inc. (FULC) Q3 2025 Earnings Call
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Q3 2025 earnings conference call, held 2025-10-29. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Alan Musso
Chief Financial Officer
Dr. Ian Frazier
Senior Vice President, Clinical Development
Kristen Kluska
Analyst at Cantor Fitzgerald
Joseph P. Schwartz
Analyst at Levering Partners
Corinne Johnson
Analyst at Goldman Sachs
Edward Tintoff
Analyst at Piper Sandler
Matthew Beigler
Analyst at Opco
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Fulcrum Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.336 Good morning, and welcome to the Fulcrum Therapeutics Third Quarter 2025 Financial Results 00:00:05.336 -- 00:00:09.320 and Business Update Conference Call. Currently, all participants are in a listen-only 00:00:09.320 -- 00:00:14.345 mode. This call is being webcast live and can be accessed on the Investors section of 00:00:14.345 -- 00:00:17.626 Fulcrum's website at www.FulcrumTX.com, 00:00:18.949 -- 00:00:20.951 and is being recorded. 00:00:20.951 -- 00:00:24.474 Please be reminded that remarks during this call may contain forward-looking statements 00:00:24.474 -- 00:00:28.955 within the meaning of the Private Securities Litigation Reform Act of 1995. 00:00:28.955 -- 00:00:33.461 may include statements about the company's future expectations and plans, clinical development 00:00:33.461 -- 00:00:36.124 timelines, and financial projections. 00:00:36.124 -- 00:00:39.909 While these forward-looking statements represent Fulcrum's views as of today, this should 00:00:39.909 -- 00:00:43.874 not be relied upon as representing the company's views in the future. 00:00:43.874 -- 00:00:47.579 Fulcrum may update these statements in the future, but is not taking on any obligation 00:00:47.579 -- 00:00:52.084 to do so. Please refer to Fulcrum's most recent followings with the Securities and Exchange 00:00:52.084 -- 00:00:55.949 Commission for discussions of certain risks and uncertainties associated with the company's 00:00:55.949 -- 00:00:57.949 business. 00:00:58.165 -- 00:01:02.771 Leading the call today will be Alex Sapir, CEO and President of Fulcrum. 00:01:02.771 -- 00:01:06.617 Joining Alex on the call are Alan Musso, Chief Financial Officer, and Dr. 00:01:06.617 -- 00:01:09.801 Ian Frazier, Senior Vice President, Clinical Development....